Ribocure Pharmaceuticals AB
- Address
- Vetenskapens Grand 11, 431 53 Mölndal, Sweden
Ribocure Pharmaceuticals AB - Cardiometabolic Research Center
Ribocure Pharmaceuticals AB is a specialized research organization focused on developing innovative therapeutic solutions for cardiovascular and metabolic disorders. The center demonstrates particular expertise in conducting advanced clinical trials targeting complex cardiometabolic conditions where traditional treatment options may be limited.
- Coronary artery disease and cardiovascular risk management
- Dyslipidemia and lipid metabolism disorders
- Heart failure with renal complications
The organization's research portfolio emphasizes novel pharmacological interventions for patients with stable coronary artery disease, mixed dyslipidemia, and heart failure complicated by moderate renal impairment. Their clinical development programs employ rigorous randomized, double-blind, placebo-controlled methodologies to evaluate both safety and efficacy profiles of investigational compounds. With a focus on subcutaneous and oral drug delivery systems, Ribocure Pharmaceuticals conducts Phase Ib and Phase II trials that assess pharmacokinetics, pharmacodynamics, and therapeutic outcomes in carefully selected patient populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Ribocure Pharmaceuticals AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ribocure Pharmaceuticals AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ribocure Pharmaceuticals AB
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of RBD5044 Sodium in Patients with Mixed Dyslipidemia: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial | Ribocure Pharmaceuticals AB | Phase II | Recruiting | Jan 2025 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2024-08-28 | 2024-08-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.